BULLETIN V2026-2456
PHARMACORP RX INC. ("PCRX") ("PCRX.WT")
BULLETIN TYPE: Prospectus-Unit Offering
BULLETIN DATE: July 27, 2026
TSX Venture Tier 2 Company
Financing Type: Bought Deal Prospectus Offering
Gross Proceeds: $11,500,092.00
Offering: 22,549,200 Listed Shares with 11,274,600 Warrants
Offering Price: $0.51 per Unit
Warrant Exercise Terms: $0.60 per Listed Share until July 14, 2028.
Overallotment Option: The underwriters may purchase a maximum of 2,941,200 Units for overallotment purposes. As of July 14, 2026, such option has been fully exercised. All information presented herein includes such exercise.
Commissions in Securities: # Broker Warrant
(Aggregate # of Brokers: 3) 647,076
Broker Warrant Terms: Each Broker Warrant is non-transferable and exercisable into (1) Broker Unit at $0.51 for a period of 18 months from the date of issuance. Each Broker Unit is comprised of (1) Listed Share and (1/2) Warrant. Each whole Warrant is exercisable at an exercise price of $0.60 until July 14, 2028.
Disclosure: Refer to the prospectus dated July 9, 2026 and company's news release(s) dated July 7, 2026, and July 14, 2026
_______________________________________
|
|
